Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin
暂无分享,去创建一个
Lode Wyns | Manfred Wuhrer | Stefan D Knight | Devapriya Choudhury | L. Wyns | D. Choudhury | S. Langermann | J. Pinkner | S. Hultgren | S. Knight | H. De Greve | E. D. De Genst | M. Wuhrer | M. Schembri | J. Bouckaert | C. Hung | Henri De Greve | P. Klemm | Per Klemm | Julie Bouckaert | S. Oscarson | Erwin De Genst | Scott J Hultgren | Rikard Slättegård | Stefan Oscarson | Jenny Berglund | Mark Schembri | Lieve Cools | Chia-Suei Hung | Jerome Pinkner | Anton Zavialov | Solomon Langermann | A. Zavialov | Rikard Slättegård | J. Berglund | L. Cools
[1] T. Sun,et al. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] QUANTITATIVE STUDIES , 1967 .
[3] R Möllby,et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.
[4] W. Stamm,et al. Urinary tract infection , 2010 .
[5] G. Waksman,et al. Structural biology of bacterial pathogenesis. , 2004, Current Opinion in Structural Biology.
[6] R. Kolter,et al. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.
[7] A. Levitzki,et al. An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Hultgren,et al. Bacterial Invasion Augments Epithelial Cytokine Responses to Escherichia coli Through a Lipopolysaccharide-Dependent Mechanism1 , 2001, The Journal of Immunology.
[9] H. Hasman,et al. Expression and purification of the mannose recognition domain of the FimH adhesin. , 2000, FEMS microbiology letters.
[10] P. de Man,et al. Bacterial virulence in urinary tract infection. , 1987, Infectious disease clinics of North America.
[11] S. Nishimura,et al. Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands , 2002, Chembiochem : a European journal of chemical biology.
[12] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[13] K R Anumula,et al. Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. , 1994, Analytical biochemistry.
[14] V. Stojanoff,et al. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. , 1999, Science.
[15] Stefan D Knight,et al. Structure and Biogenesis of the Capsular F1 Antigen from Yersinia pestis Preserved Folding Energy Drives Fiber Formation , 2003, Cell.
[16] C. Brinton. Non-Flagellar Appendages of Bacteria , 1959, Nature.
[17] G. Waksman,et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection , 2002, Molecular microbiology.
[18] S. Oscarson,et al. Syntheses of deoxy analogues of methyl 3,6-di-O-alpha-D-mannopyranosyl-alpha-D-mannopyranoside for studies of the binding site of concanavalin A. , 1995, Carbohydrate Research.
[19] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[20] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[21] M. Sanner,et al. Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.
[22] S. Knight,et al. Structural basis for bacterial adhesion in the urinary tract. , 2003, Advances in experimental medicine and biology.
[23] T. Silhavy,et al. On the significance of the retention of ligand by protein. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Glockshuber,et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. , 2001, Journal of cell science.
[25] G. Waksman,et al. Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor , 2001, Cell.
[26] A. Vagin,et al. MOLREP: an Automated Program for Molecular Replacement , 1997 .
[27] S. Langermann,et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.
[28] S. Falkow,et al. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili , 1985, Journal of bacteriology.
[29] N. W. Davis,et al. The complete genome sequence of Escherichia coli K-12. , 1997, Science.
[30] Lode Wyns,et al. The fimbrial adhesin F17‐G of enterotoxigenic Escherichia coli has an immunoglobulin‐like lectin domain that binds N‐acetylglucosamine , 2003, Molecular microbiology.
[31] J. Berglund,et al. Bacterial adhesins: structural studies reveal chaperone function and pilus biogenesis. , 2000, Current opinion in chemical biology.
[32] Dina,et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells , 1989, Antimicrobial Agents and Chemotherapy.
[33] N. Firon,et al. Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria , 1984, Infection and immunity.
[34] N. Brown,et al. Molecular Microbiology , 1998, NATO ASI Series.
[35] M. Mulvey,et al. Adhesion and entry of uropathogenic Escherichia coli , 2002, Cellular microbiology.
[36] M. Footer,et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Hultgren,et al. PapD-like chaperones and pilus biogenesis. , 2000, Seminars in cell & developmental biology.
[38] C. Bloch,et al. A key role for type 1 pili in enterobacterial communicability , 1992, Molecular microbiology.
[39] Thisbe K Lindhorst,et al. Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary α-mannosyl clusters: The effect of multivalency , 1998, Glycoconjugate Journal.
[40] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[41] S. Hultgren,et al. The chaperone/usher pathway: a major terminal branch of the general secretory pathway. , 1998, Current opinion in microbiology.
[42] J. Walker,et al. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. , 1996, Journal of molecular biology.
[43] D. Stevens,et al. Structural Biology of Bacterial Pathogenesis , 2006, Emerging Infectious Diseases.
[44] C. Tang,et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract , 2002, Molecular microbiology.
[45] S. Oscarson,et al. Syntheses of the octyl and tetradecyl glycosides of 3,6-di-O-α-d-mannopyranosyl-α-d-mannopyranose and of 3,4-di-O-α-d-mannopyranosyl-α-d-mannopyranose. A new way for 2,4-di-O-protection of mannopyranosides , 1993 .
[46] L. Wyns,et al. Structural basis of carbohydrate recognition by the lectin LecB from Pseudomonas aeruginosa. , 2003, Journal of molecular biology.
[47] J Navaza,et al. Implementation of molecular replacement in AMoRe. , 2001, Acta crystallographica. Section D, Biological crystallography.
[48] Ankur H. Shah,et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. , 1997, The Journal of clinical investigation.
[49] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[50] R. Bollinger,et al. Immunoglobulin-Mediated Agglutination of and Biofilm Formation by Escherichia coli K-12 Require the Type 1 Pilus Fiber , 2004, Infection and Immunity.
[51] M. Schembri,et al. Global gene expression in Escherichia coli biofilms , 2003, Molecular microbiology.
[52] W. Wooster,et al. Crystal structure of , 2005 .
[53] A. Lundblad,et al. The Pk Antigen as Receptor for the Haemagglutinin of Pyelonephritic Escherichia coli , 1980 .
[54] A. Schaeffer,et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli , 1985, Infection and immunity.
[55] N. Firon,et al. Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium. , 1983, Carbohydrate research.
[56] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[57] Jörgen Ohlsson,et al. Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides. , 2003, Bioorganic & medicinal chemistry.
[58] L. Wyns,et al. Crystal Structure of Pterocarpus angolensis Lectin in Complex with Glucose, Sucrose, and Turanose* , 2003, The Journal of Biological Chemistry.
[59] R. Glockshuber,et al. Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. , 2002, Journal of molecular biology.
[60] S. Normark,et al. The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[61] S. Langermann,et al. Development of a recombinant FimCH vaccine for urinary tract infections. , 2003, Advances in experimental medicine and biology.
[62] Quincy Teng,et al. Structural Biology , 2013, Springer US.
[63] S. Falkow,et al. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate , 1981, Infection and immunity.
[64] Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998 .
[65] D. Old. Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates. , 1972, Journal of general microbiology.
[66] H. Leffler,et al. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes , 1980 .
[67] N. Firon,et al. Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells , 1987, Infection and immunity.
[68] N. Firon,et al. Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coli. , 1982, Biochemical and biophysical research communications.
[69] A. Schaeffer,et al. Urinary tract infection in adults: research priorities and strategies. , 2001, International journal of antimicrobial agents.
[70] H. Mizoguchi,et al. Extensive Genomic Diversity in Pathogenic Escherichia coli and Shigella Strains Revealed by Comparative Genomic Hybridization Microarray , 2004, Journal of bacteriology.
[71] H R Powell,et al. The Rossmann Fourier autoindexing algorithm in MOSFLM. , 1999, Acta crystallographica. Section D, Biological crystallography.
[72] G. Waksman,et al. Structural basis of chaperone function and pilus biogenesis. , 1999, Science.
[73] R M Esnouf,et al. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.
[74] B. Koellreutter,et al. Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins , 1986, Infection and immunity.
[75] B. Uhlin,et al. Regulatory cross‐talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein , 2000, The EMBO journal.
[76] P Bork,et al. The immunoglobulin fold. Structural classification, sequence patterns and common core. , 1994, Journal of molecular biology.
[77] T. Hooton,et al. Diagnosis and treatment of uncomplicated urinary tract infection. , 1997, Infectious disease clinics of North America.
[78] G. Waksman,et al. Chaperone Priming of Pilus Subunits Facilitates a Topological Transition that Drives Fiber Formation , 2002, Cell.
[79] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.